drugset / Trial / NCT00163501

Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)

NCT00163501

Phase 3 Completed 600 enrolled AstraZeneca
RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate the safety and effectiveness of ciclesonide nasal spray as compared with placebo (inactive substance) nasal spray in relieving symptoms of perennial allergic rhinitis.

Timeline

Start
2003-12
Primary completion
2005-04
Completion
2005-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Ciclesonide Other / unclassified 200 ug Intranasal